JUN and prostate carcinoma: Regretfully, our current study could not explain why gemcitabine induced the upregulation of miR-222-3p in NSCLC, although some studies reported that nuclear factor (NF)-κB and c-Jun can induce the expression of miR-221&222 in prostate carcinoma and glioblastoma cells.